Replies to post #14321 on Momenta Pharmaceuticals, Inc. (MNTA)

[GrthzGd]

Good summary. It's a bit disappointing that the analysts wouldn't touch the litigation with a ten foot pole. Ironic too, that having fouled the Enoxaparin nest, AMPH is now vocally counting on collecting on MNTA's $100M bond to bail itself out from its losses.